Novel 5α‐steroid reductase (SRD5A3, type‐3) is overexpressed in hormone‐refractory prostate cancer

Motohide Uemura(The University of Tokyo), Hidewaki Nakagawa(RIKEN Center for Integrative Medical Sciences), Yusuke Nakamura(Rissho University), Äkïhïko Okuyama(The University of Osaka), Suyoun Chung(OncoTherapy Science (Japan)), Seijiro Honma, Kenji Tamura(Neurology, Inc)
Cancer Science
November 6, 2007
Cited by 259


Related Papers